Literature DB >> 19661195

Patient and practitioner influences on the placebo effect in irritable bowel syndrome.

John M Kelley1, Anthony J Lembo, J Stuart Ablon, Joel J Villanueva, Lisa A Conboy, Ray Levy, Carl D Marci, Catherine E Kerr, Irving Kirsch, Eric E Jacobson, Helen Riess, Ted J Kaptchuk.   

Abstract

OBJECTIVE: To determine whether placebo responses can be explained by characteristics of the patient, the practitioner, or their interpersonal interaction.
METHODS: We performed an analysis of videotape and psychometric data from a clinical trial of patients with irritable bowel syndrome who were treated with placebo acupuncture in either a warm empathic interaction (Augmented, n = 96), a neutral interaction (Limited, n = 97), or a waitlist control (Waitlist, n = 96). We examined the relationships between the placebo response and a) patient personality and demographics; b) treating practitioner; and c) the patient-practitioner interaction as captured on videotape and rated by the Psychotherapy Process Q-Set.
RESULTS: Patient extraversion, agreeableness, openness to experience, and female gender were associated with placebo response, but these effects held only in the augmented group. Regression analyses controlling for all other independent variables suggest that only extraversion is an independent predictor of placebo response. There were significant differences between practitioners in outcomes; this effect was twice as large as the effect attributable to treatment group assignment. Videotape analysis indicated that the augmented group fostered a treatment relationship similar to a prototype of an ideal healthcare interaction.
CONCLUSIONS: Personality and gender influenced the placebo response, but only in the warm, empathic, augmented group. This suggests that, to the degree a placebo effect is evoked by the patient-practitioner relationship, personality characteristics of the patient will be associated with the placebo response. In addition, practitioners differed markedly in effectiveness, despite standardized interactions. We propose that the quality of the patient-practitioner interaction accounts for the significant difference between the groups in placebo response.

Entities:  

Mesh:

Year:  2009        PMID: 19661195      PMCID: PMC2818141          DOI: 10.1097/PSY.0b013e3181acee12

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  37 in total

1.  Clinical competence assessment in radiology: introduction of an objective structured clinical examination in the medical school curriculum.

Authors:  E Morag; G Lieberman; K Volkan; K Shaffer; R Novelline; E V Lang
Journal:  Acad Radiol       Date:  2001-01       Impact factor: 3.173

2.  Validity of controlled clinical trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program.

Authors:  J Stuart Ablon; Enrico E Jones
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

Review 3.  Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.

Authors:  A Hróbjartsson; P C Gøtzsche
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

Review 4.  A review of therapist characteristics and techniques positively impacting the therapeutic alliance.

Authors:  Steven J Ackerman; Mark J Hilsenroth
Journal:  Clin Psychol Rev       Date:  2003-02

5.  Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial.

Authors:  E V Lang; E G Benotsch; L J Fick; S Lutgendorf; M L Berbaum; K S Berbaum; H Logan; D Spiegel
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

6.  The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study.

Authors:  L Keefer; E B Blanchard
Journal:  Behav Res Ther       Date:  2001-07

7.  Influence of context effects on health outcomes: a systematic review.

Authors:  Z Di Blasi; E Harkness; E Ernst; A Georgiou; J Kleijnen
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

8.  Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome.

Authors:  T Lembo; R A Wright; B Bagby; C Decker; S Gordon; P Jhingran; E Carter
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

9.  "Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled trial.

Authors:  Ted J Kaptchuk; Jessica Shaw; Catherine E Kerr; Lisa A Conboy; John M Kelley; Thomas J Csordas; Anthony J Lembo; Eric E Jacobson
Journal:  Cult Med Psychiatry       Date:  2009-09

10.  Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

Authors:  Douglas A Drossman; Brenda B Toner; William E Whitehead; Nicholas E Diamant; Chris B Dalton; Susan Duncan; Shelagh Emmott; Valerie Proffitt; Donna Akman; Karen Frusciante; Terry Le; Kim Meyer; Barbara Bradshaw; Kristi Mikula; Carolyn B Morris; Carlar J Blackman; Yuming Hu; Huanguang Jia; Jim Z Li; Gary G Koch; Shrikant I Bangdiwala
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

View more
  65 in total

Review 1.  [Placebo responders in randomized controlled drug trials of fibromyalgia syndrome : Systematic review and meta-analysis].

Authors:  W Häuser; E Bartram-Wunn; C Bartram; T R Tölle
Journal:  Schmerz       Date:  2011-12       Impact factor: 1.107

2.  Adherence, placebo effects, and mortality.

Authors:  Ira B Wilson
Journal:  J Gen Intern Med       Date:  2010-12       Impact factor: 5.128

3.  Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.

Authors:  F Cremonini; D C Ziogas; H Y Chang; E Kokkotou; J M Kelley; L Conboy; T J Kaptchuk; A J Lembo
Journal:  Aliment Pharmacol Ther       Date:  2010-03-26       Impact factor: 8.171

Review 4.  Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healing.

Authors:  Ted J Kaptchuk
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

Review 5.  Childhood functional abdominal pain: mechanisms and management.

Authors:  Judith Korterink; Niranga Manjuri Devanarayana; Shaman Rajindrajith; Arine Vlieger; Marc A Benninga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-10       Impact factor: 46.802

6.  Group analysis versus individual response: the inferential limits of randomized controlled trials.

Authors:  John M Kelley; Ted J Kaptchuk
Journal:  Contemp Clin Trials       Date:  2010-07-16       Impact factor: 2.226

7.  "Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled trial.

Authors:  Ted J Kaptchuk; Jessica Shaw; Catherine E Kerr; Lisa A Conboy; John M Kelley; Thomas J Csordas; Anthony J Lembo; Eric E Jacobson
Journal:  Cult Med Psychiatry       Date:  2009-09

8.  Effectiveness of manual therapies: the UK evidence report.

Authors:  Gert Bronfort; Mitch Haas; Roni Evans; Brent Leininger; Jay Triano
Journal:  Chiropr Osteopat       Date:  2010-02-25

9.  Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: a randomized trial.

Authors:  Andrea Horvath; Piotr Dziechciarz; Hania Szajewska
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

10.  Placebo analgesia and reward processing: integrating genetics, personality, and intrinsic brain activity.

Authors:  Rongjun Yu; Randy L Gollub; Mark Vangel; Ted Kaptchuk; Jordan W Smoller; Jian Kong
Journal:  Hum Brain Mapp       Date:  2014-02-27       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.